News
The two biggest weight-loss drugmakers have lost $252bn in value this year, as investor enthusiasm for obesity treatments ...
The integration aims to simplify access to Zepbound for eligible members while providing comprehensive, whole-person care to ...
The pricing of weight-loss and diabetes drugs like Lilly’s Zepbound and Mounjaro, and Novo’s Wegovy and Ozempic, is a ...
The NHS will prescribe the weight-loss jab Mounjaro to more people in response to a dramatic price increase for private ...
A growing wave of lawsuits is targeting Novo Nordisk, the manufacturer of the widely used drugs Ozempic and Wegovy, following ...
Many Mounjaro users are looking into alternative medications following news of a 170 percent price increase in the UK ...
While it’s been easy to grow a bit desensitized to the seemingly unstoppable sales growth of Novo Nordisk and Eli Lilly’s | ...
8h
TipRanks on MSNHere’s Why Wall Street Is Cautious on Hims & Hers Health Stock (HIMS)
Telehealth and wellness platform Hims & Hers Health ($HIMS) recently disappointed investors with its mixed second-quarter ...
MAKERS of the fat jab Wegovy say they will not increase the price of the drug when the cost of rival Mounjaro doubles next ...
Celeste Ntuli opened up on her battle with obesity. The star's comments comes as Mzansi is discussing the new looks of celebs ...
Johannesberg: Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa and stepping up competition with Eli Lilly's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results